Ameriprise’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Ameriprise’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-116,141	Closed	-$4.79M	–	4126
2015 Q2	$4.79M	Buy	116,141 +1,921	+2%	+$68.9K	﹤0.01%	2181
2015 Q1	$4.03M	Buy	114,220 +5,209	+5%	+$176K	﹤0.01%	2217
2014 Q4	$3.5M	Buy	109,011 +1,464	+1%	+$42.3K	﹤0.01%	2275
2014 Q3	$3.02M	Buy	107,547 +4,267	+4%	+$130K	﹤0.01%	2323
2014 Q2	$3.12M	Buy	103,280 +4,010	+4%	+$111K	﹤0.01%	2335
2014 Q1	$2.75M	Buy	99,270 +1,220	+1%	+$31.9K	﹤0.01%	2356
2013 Q4	$2.5M	Buy	98,050 +3,151	+3%	+$97.1K	﹤0.01%	2373
2013 Q3	$2.84M	Buy	94,899 +3,795	+4%	+$106K	﹤0.01%	2285
2013 Q2	$2.62M	Buy	+91,104	New	+$2.51M	﹤0.01%	2237

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Ameriprise's BRLI Position: Q3 2015 in Review

Ameriprise sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 116,141 shares — an estimated $4.79M sold.

Ameriprise first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $4.79M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Ameriprise reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Ameriprise sold 116,141 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $4.79M.
Ameriprise first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Ameriprise's BIO-REFERENCE LABS INC-NEW- position peaked at $4.79M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Ameriprise's 13F filing for Q3 2015, filed 12 Nov 2015.